MissionIR Articles
-
MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Expands Growth Strategy in Latin America
CISO Global Inc. (NASDAQ: CISO), rebranding from Cerberus Cyber Sentinel Corp., an industry leader in managed cybersecurity and compliance services, is expanding its existing footprint in Latin America. “This is in keeping with global cyber…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Hospital Contract Renewal for Seventh Year
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced that a long-time healthcare client has renewed its K5 Autonomous Security Robot (“ASR”) contract for the seventh…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at an upcoming Virtual Investor GBM…
-
Market Analysis Endorsement Boosts Prospects of OTR Shipping Optimizer Freight Technologies Inc. (NASDAQ: FRGT)
Over-the-road shipping technology innovator Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) has earned a positive reception in market analysis as the company works to move businesses’ merchandise more efficiently between producers and consumers throughout the United States-Mexico-Canada…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Positioned to Capitalize on Forthcoming Resources Discoveries
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently commenced trading on the Toronto Stock Exchange…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Files Lawsuit for Damages Sustained from False Article
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a civil complaint for defamation in the Superior Court of Delaware. The complaint alleges that on March 22, 2023,…
-
Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility of Using Ketamine Formulations as an Alternative Treatment for Fibromyalgia
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced that it had achieved a positive outcome for its toxicology study of SP-26, its novel time-released,…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host Town Hall Marathon
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, today announced its plans to hold 10 Town Halls during the first 10 days of April 2023. The event…
-
CISO Global Inc. (NASDAQ: CISO) Committed to Building Client Trust, Attains ‘Highest Standard’ with SOC 2 Certification
As an industry leader in global cybersecurity and compliance services, CISO Global (NASDAQ: CISO), formerly Cerberus Cyber Sentinel Corp., recently reached a significant milestone (https://ibn.fm/BNFYO). The company announced that it has achieved SOC 2(R) Type…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application titled “Methods and Compositions for Pain Management.” The…
-
Answer to Global Warming Isn’t Always Cars, It’s Trash and EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Has a Solution
There is finger pointing everywhere to single-out culprits in climate change, and exhaust-spewing fossil fuel-powered cars are an easy target. The reality is that, while it may sound great in theory, simply replacing all the…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma and neuro-oncology, just enrolled its first patient in Spain, marking a key…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Board-Approved Action to Regain Compliance with NASDAQ Market Requirements
Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, has announced a reverse share split. The move is designed to increase the market price per share of the company’s ordinary share, thereby resulting…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Efforts to Boost Commercial Prospects ‘Paying off in Spades’
Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator developing and commercializing its patented DehydraTECH(TM) drug delivery technology. Lexaria is continuing and/or initiating discussions with several larger companies in Europe and North America regarding the…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Holds Potential to Combat New COVID-19 Variants
BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. “BiondVax is seeing convincingly positive outcomes for preventing and arresting…
-
MissionIRNewsBreaks – Why Progressive Care Inc. (RXMD) Is ‘One to Watch’
Progressive Care (OTCQB: RXMD) is an organization based in Florida that, through its wholly owned subsidiaries PharmcoRx Pharmacy and ClearMetrX, offers personalized care services and technology to support the managed health care industries. “Progressive Care…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psychedelic Drugs Market
Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. “Silo Pharma has distinguished itself amongst peers for its ground-breaking research into conditions such as post-traumatic stress disorder…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Poised to Enable Expedited Care for Heart Attack Patients
HeartBeam (NASDAQ: BEAT) is developing the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. “By applying a suite of proprietary algorithms to simplify vector electrocardiography (‘VECG’), the HeartBeam platform will enable…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Drug Delivery Technology Demonstrates Growing List of Potential Applications as Evidenced Through Numerous R&D Programs
Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing bioavailability and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Receives Order from Florida University, Notes Media Day Spotlighting OCCC’s New Robot
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an order for three of its K1 Blue Light Emergency Phones from a southern Florida university. The…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option